Viatris (VTRS) Interest Coverage Ratio Growth (3y) (2023 - 2026)
Powered by 
Analysis
Viatris (VTRS) Interest Coverage Ratio Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | -72.71% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn | -40.53% |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn | 13.10% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -55.02% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn | -16.49% |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn | 370.83% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -72.71% |
| Mar 31, 2026 | -30.92% |
| Dec 31, 2025 | -5.59% |
| Sep 30, 2025 | -25.78% |
| Jun 30, 2025 | -19.00% |
| Mar 31, 2025 | -92.72% |
| Dec 31, 2024 | -41.89% |
| Sep 30, 2024 | -12.98% |
| Jun 30, 2024 | -79.17% |
| Mar 31, 2024 | 43.18% |
| Dec 31, 2023 | 19.14% |
| Mar 31, 2023 | 20.86% |